ArticleBMC geriatrics2026
Development and validation of a screening tool for sarcopenia in community-dwelling older adults: a diagnostic cross-sectional study.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe early identification of sarcopenia, a condition linked to serious functional decline in older adults, is critical for intervention. However, there is currently a lack of accurate and efficient tools for rapid screening and self-screening. The aim of the study was to create a novel, user-friendly prediction tool for rapid community screening of sarcopenia among Chinese older adults, along with an easy-to-operate and self-screening tool for home use.
methodsThis cross-sectional study was conducted in community settings, and used univariate and multiple logistic regression to select predictors and develop prediction models. A user-friendly nomogram was developed based on the simplified model and translated into a publicly accessible online tool. Model performance was evaluated by the area under the receiver operating curve (AUROC) for discrimination, calibration curve for calibration, and decision curve analysis (DCA) for clinical utility.
resultsA total of 2,453 individuals aged ≥ 60 years were included and randomly split into training and validation sets (7:3). In the training dataset, optimal model (Model 1) includes six variables: age, sex, BMI, calf circumference (CC), diastolic blood pressure, and sitting duration (mean daily sitting hours on weekdays in the past week) with an AUROC of 0.8720 (95% CI, 0.8510–0.8930). The simplified model (Model 2) retained four predictors (age, sex, BMI, CC) and achieved an AUROC of 0.8688 (95% CI, 0.8476–0.8900). In the validation dataset, the simplified model (Model 2) yielded an AUROC of 0.8465 (95% CI, 0.8102–0.8828). At a threshold probability of 0.111, the sensitivity and specificity were 0.8683 (95% CI, 0.8258–0.9108) and 0.7186 (95% CI, 0.6957–0.7416) for simplified model (Model 2), 0.7941 (95% CI, 0.7156–0.8726) and 0.7062 (95% CI, 0.6707–0.7416) for validation model (Model 3). Calibration was good, and DCA indicated clinical utility.
conclusionsThe study developed a high-performance prediction tool that serves as a low-cost, user-friendly, and freely accessible online tool for community and self-screening of sarcopenia, facilitating personalized early prevention strategies and optimizing healthcare resource utilization. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.